• Phone: 080 42136299
  • Email: info@bionovasupplies.in

InSphero and Bionova Supplies signed a distribution agreement to accelerate the development of spheroid and organoid cultures in India

April 25, 2023 | Schlieren, Switzerland
InSphero AG, the pioneer of 3D cell-based assay technology, announced that the company is making their patented Akura™ 96 and 384 Spheroid Microplates available to researchers in the Indian market by signing a distribution agreement with  Bionova Supplies , the leading supplier of world class brand in the field of Biotechnology and Scientific Instruments in India. “The Akura™ Plate Formats, engineered specifically for 3D cultures of spheroids and organoids, simplify aggregation and handling of spheroids and organoids and facilitates integration of 3D models into cell-based assay workflows” said Dr. Frauke Greve, Senior product manager at InSphero. “We are excited to support local researchers with our industry-ready solutions which will help them accelerate their innovative work.” Over 10 years of development in cooperation with cell culture experts has resulted in a scalable and reproducible microplate design with superior functionality:

  • The plates have the unique SureXchange™ feature to prevent unintended spheroid and organoid aspiration during near-complete medium exchange required in many applications and proved to be a key enabler for robust lab automation and screening programs
  • A highly stable, non-adherent surface coating preserves spheroid/organoid morphology and functionality in long-term cultures
  • The ANSI/SLAS plates allow enhanced imaging speed, resolution and improved high content image quality

To complement the ultra-low attachment (ULA) Akura™ Spheroid Microplates, the Akura™ Plus Hanging-drop plates are engineered to enable gravity-assisted formation of uniform spheroids while completely preventing surface interactions of the cells. This approach is suitable for many cell types which do not normally form spheroids on ULA surfaces. Transfer of formed spheroids into Akura™ 96 Spheroid Microplates is possible in a single step.

“Building positive relationships in business is one of the most important foundations for success. It gives us an immense pleasure to have InSphero on board with their complete range of 3D Cell culture solutions” comments Sandeep C, managing partner at Bionova. “Through the extended partnership with InSphero Bionova is further unlocking the world of 3D cell culture to the Indian customers.” Get started with your 3D Cell Culture research here:  bionovasupplies.in/contact Discover Akura™ Spheroid Microplates here: shop.insphero.com

About Bionova

Bionova is a blend of young aspiring team, with highly qualified and rich experience of over a decade in Sales & Marketing serving the Lifescience Industry and Analytical Research. Founded as a partnership company in 2008, its main objective is to pave the way of world class brands in the field of Biotechnology and Scientific Instruments in India. “Relationships are key to collective success” – Bionova’s credo implies the long- term and strong association with customers. Application driven approach and in time services to customers made Bionova to stand separate from others. The core strength of Bionova is “team performance” with skilled and dedicated manpower. Bionova Vision: To be one of the preferred partners for the scientific community and to excel and be the leading suppliers in Life Science and Analytical Research.

Contact Details

Bionova Supplies
#43a, 3rd floor, 1st main road, 3rd stage, 3rd block,
Basaveshwara nagar, Bangalore – 560079
Karnataka, India
Phone: +91 80 42136299, Website: www.bionovasupplies.in

About InSphero
InSphero is the pioneer of industrial-grade, 3D-cell-based assay solutions and scaffold- free 3D organ-on-a-chip technology. InSphero’s technology platform empowers pharmaceutical and biotechnology researchers to successful and predictive decision- making by accurately rebuilding human physiology in vitro. Its robust and precisely engineered suite of 3D InSight™ human tissue platforms are used by major pharmaceutical companies worldwide to increase efficiency in drug discovery and safety testing. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and oncology (with a focus on immuno- oncology and PDX models). The scalable Akura™ technology underlying the company’s 3D InSight™ Discovery and Safety Platforms includes 96 and 384-well plate formats and the Akura™ Flow organ-on-a-chip system to drive efficient innovation throughout all phases of drug development.